SCHEDULE: Hudson Bay Capital Amends Stake in Drugs Made In America
Beneficial Ownership Report (Schedule 13G Amendment)
Hudson Bay Capital Management LP and Sander Gerber report a 4.62% beneficial ownership stake in Drugs Made In America Acquisition Corp. ordinary shares.
Summary
- Hudson Bay Capital Management LP and Sander Gerber have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Drugs Made In America Acquisition Corp.
- The reporting persons collectively beneficially own 1,550,000 ordinary shares of Drugs Made In America Acquisition Corp.
- This ownership represents 4.62% of the company's ordinary shares outstanding.
- The percentage is calculated based on 33,517,143 ordinary shares outstanding as of August 14, 2025, as reported in the company's Form 10-Q.
- Hudson Bay Capital Management LP serves as the investment manager to HB Strategies LLC, which holds the securities.
- Sander Gerber is the managing member of Hudson Bay Capital GP LLC, the general partner of the Investment Manager, and disclaims beneficial ownership of these securities.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that would inherently suggest a positive or negative sentiment regarding the issuer's performance or prospects.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
This filing is a routine disclosure of beneficial ownership by an investment manager and its principal, indicating a passive investment stake in a Special Purpose Acquisition Company (SPAC). It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant ownership stake held by an investment firm, which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 08/14/2025 | Date as of which 33,517,143 ordinary shares outstanding were reported in the Company's Form 10-Q. |
| 09/30/2025 | Date of event which requires filing of this statement. |
| 11/12/2025 | Date of filing and signature by reporting persons. |
Keywords
beneficial ownership, Schedule 13G, Hudson Bay Capital Management, Drugs Made In America Acquisition Corp., ordinary shares, investment management, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.